The risk of acute radiocontrast-mediated kidney injury following endovascular therapy for acute ischemic stroke is low

American Journal of Neuroradiology

Volumn 31, Issue 9, 2010, Pages 1584-1587

  Loh, Yince ^a,c   McArthur, D L ^a   Vespa, P ^a   Shi, Z S ^a,b   Liebeskind, D S ^a   Jahan, R ^a   Gonzalez, N R ^a   Starkman, S ^a   Saver, J L ^a   Tateshima, S ^a   Duckwiler, G R ^a   Vinuela F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IOHEXOL; NONSTEROID ANTIINFLAMMATORY AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; CAROTID ANGIOPLASTY; CAROTID ARTERY STENTING; CHRONIC KIDNEY FAILURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DEATH; DIABETES MELLITUS; DRUG EXPOSURE; FEMALE; HOSPITAL ADMISSION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ACUTE KIDNEY INJURY; BRAIN ISCHEMIA; COMORBIDITY; CONTRAST MEDIA; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; STROKE; SURVIVAL ANALYSIS; SURVIVAL RATE; WASHINGTON;

EID: 77958604896     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2136     Document Type: Article

References (26)

1. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: PROACT Investigators-Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11
2. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study - a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11
3. Gobin YP, Starkman S, Duckwiler GR, et al. MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004;35:2848-54
4. Smith WS, Sung G, Starkman S, et al, for the MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-38
5. The Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-68. Epub 2009 Jul 9
6. Kurnik BR, Allgren RL, Genter FC, et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998;31:674-80
7. Margulies KB, McKinley LJ, Cavero PG, et al. Induction and prevention of radiocontrast-induced nephropathy in dogs with heart failure. Kidney Int 1990;38:1101-08
8. Heyman SN, Reichman J, Brezis M. Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia. Invest Radiol 1999;34:685-91
9. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930-36
10. Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004;93:1515-9
11. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older: a prospective study. Arch Intern Med 1990;150:1237-42
12. Maeder M, Klein M, Fehr T, et al. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 2004;44:1763-71
13. Longstreth WT Jr, Bernick C, Fitzpatrick A, et al. Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology 2001;56:368-75
14. Mehta RL, Kellum JA, Shah SV, et al, for the Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31
15. Wickenbrock I, Perings C, Maagh P, et al. Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI. Clin Res Cardiol 2009;98:765-72. Epub 2009 Oct 23
16. Jabara R, Gadesam RR, Pendyala LK, et al. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention. Am J Cardiol 2009;103:1657-62
17. Marenzi G, Assanelli E, Campodonico J, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 2009;150:170-77
18. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial - the Iohexol Cooperative Study. Kidney Int 1995;47:254-61
19. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-75
20. Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004;44:1780-85
21. Rodriguez GJ, Cordina SM, Vazquez G, et al. The hydration influence on the risk of stroke (THIRST) study. Neurocrit Care 2009;10:187-94. Epub 2008 Dec 3
22. Yoshida S, Kamihata H, Nakamura S, et al. Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency. J Cardiol 2009;54:192-98
23. ACT Trial Investigators. Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy. Trials 2009;10:38
24. Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006;354:2773-82
25. Barrett BJ, Parfrey PS. Clinical practice: preventing nephropathy induced by contrast medium. N Engl J Med 2006;354:379-86
26. Smith WS, Sung G, Saver JL, et al, for the Multi MERCI investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the multi MERCI trial. Stroke 2008;39:1205-12